GlobeNewsWire
28 Jul 2026, 21:31 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Celcuity Inc. (CELC) is facing a potential class action lawsuit investigation by Pomerantz LLP regarding alleged securities fraud or unlawful business practices. — Lawsuits and fraud investigations create legal uncertainty and can lead to significant financial settlements or reputational damage.
-0.60Celcuity announced a late Q3 2026 commercial launch for its FDA-approved breast cancer therapy Revtorpyk, which was slower than analyst expectations. — Delayed revenue realization from a primary product launch typically leads to downward revisions in near-term financial forecasts.
-0.40Which stocks this story touches
The company is facing a securities fraud investigation following a stock price drop due to a delayed product launch timeline.
Continue reading
6 related stories
Search tags
The company is being investigated by a law firm on behalf of investors for potential unlawful business practices.
The company is being investigated by a law firm on behalf of investors for potential unlawful business practices.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
2h ago
